Codes of Conduct


Since they were originally adopted in 1969 by the Swedish Association of the Pharmaceutical Industry (LIF) and the Association of Representatives of Foreign Pharmaceutical Industries (RUFI), the Rules governing medicinal product information have been the primary document for specifying in greater detail the responsibility of pharmaceutical companies as regards information about medicinal products.
In recent years, the LIF has, in part through its membership of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufactures and Associations (IFPMA), been covered by these organisations’ regulations. In addition, LIF has entered into a number of agreements regarding forms of cooperation between the pharmaceutical industry and healthcare etc. In addition, rules for noninterventional studies, rules for forms of co-operation with organisations/interest associations, rules for interaction between companies and personnel in veterinary care as well as rules for interaction between companies and politicians have been issued.

It is up to the Swedish marketing companies to ensure that the Ethical rules for the pharmaceutical industry are also observed by parent companies and sister companies in the event of activities on the Swedish market or targeted at the Swedish market. It is also the duty of such companies, in license agreements or similar with business partners, to enjoin them to comply with the Ethical rules for the pharmaceutical industry.

LIF’s Board of Directors has decided to gather the national and international regulations in a single code. On 13 June 2007, LIF’s Board of Directors decided to adopt the new regulation specified in the Ethical rules for the pharmaceutical industry. The regulations entered into force on 1 October 2007 and were revised in December 2014. The ethical rules for the pharmaceutical industry shall be regarded as a complement to current legislation, regulations and code of statutes issued by governmental bodies, and applicable codes, e.g. anti-bribery legislation, the Code on Gifts, Rewards and other Benefits issued by the Swedish Anti-Corruption Institute and rules on procurement.

The member companies of LIF, Föreningen Innovativa Mindre Life Science Bolag (IML) and Föreningen för Generiska Läkemedel (FGL) follow the Ethical rules.